|
Status |
Public on May 17, 2021 |
Title |
GK87 |
Sample type |
RNA |
|
|
Source name |
papillary thyroid carcinoma
|
Organism |
Homo sapiens |
Characteristics |
histological variant: Classical tissue type: lymph node metastasis post RAI collection before/after rai: After patient id: pt_39 patient rai responce: Refractory rai uptake at the metastatic site: No disease: Persistence lesion by ptc-ma: TERT250 lesion class: pTERT patients with available multiple tumor tissues: No tumor purity class by cibersort: low purity
|
Treatment protocol |
Patients RAI treatment following tumor surgical resection (thyroidectomy)
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted from snap-frozen tissues using Qiagen miRNeasy Mini Kit and quantified by Qubit 2.0 Fluorometer (Thermo Fisher).
|
Label |
Cy3
|
Label protocol |
RNA was labeled and processed according to manufacturer’s recommended protocols.
|
|
|
Hybridization protocol |
Hybridization was performed according to manufacturer’s standard protocols.
|
Scan protocol |
miRNA microarrays were scanned with Agilent SureScan Microarray Scanner
|
Description |
39_L microRNA expression profiles from papillary thyroid carcinoma
|
Data processing |
Scanned images were processed with Agilent Feature Extraction v10.7 with default parameters to obtain raw data. Raw data were imported in R and processed using the limma package. Spot-level raw intensities were background-corrected using the normexp method and normalized with quantile normalization.
|
|
|
Submission date |
May 26, 2020 |
Last update date |
May 17, 2021 |
Contact name |
Matteo Dugo |
E-mail(s) |
[email protected]
|
Organization name |
IRCCS Ospedale San Raffaele
|
Department |
Department of Medical Oncology
|
Street address |
via Olgettina 60
|
City |
Milan |
ZIP/Postal code |
20132 |
Country |
Italy |
|
|
Platform ID |
GPL21575 |
Series (2) |
GSE151180 |
Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset) |
GSE151181 |
Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas |
|